MILESTONE SCIENTIFIC INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
MLSS$0.300.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,112,642 | $3,258,058 |
| Accounts receivable, net of allowance for credit losses of $10,000, respectively | 680,620 | 475,376 |
| Accounts receivable, related party | 25,548 | - |
| Prepaid expenses and other current assets | 468,792 | 564,645 |
| Inventories | 3,781,837 | 3,713,215 |
| Advances on contracts | 1,408,395 | 1,275,260 |
| Total current assets | 7,477,834 | 9,286,554 |
| Furniture, fixtures and equipment, net | 19,193 | 12,921 |
| Intangibles, net | 79,063 | 148,404 |
| Right of use assets finance lease | 55,811 | 67,201 |
| Right of use assets operating lease | 150,378 | 257,842 |
| Other assets | 24,150 | 24,150 |
| Total assets | $7,806,429 | $9,797,072 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,430,250 | $1,021,393 |
| Accounts payable, related party | 1,359,698 | 493,313 |
| Accrued expenses and other payables | 995,206 | 1,796,319 |
| Accrued expenses, related party | 188,406 | 304,293 |
| Current portion of finance lease liabilities | 27,347 | 12,530 |
| Current portion of operating lease liabilities | 130,355 | 116,279 |
| Total current liabilities | 4,131,262 | 3,744,127 |
| Non-current portion of finance lease liabilities | 27,336 | 54,672 |
| Non-current portion of operating lease liabilities | 35,208 | 165,573 |
| Convertible notes payable, related parties | 800,000 | - |
| Total liabilities | $4,993,806 | $3,964,372 |
| Commitments and contingencies | - | - |
| Stockholders’ equity | ||
| Common stock, par value $0.001; authorized 125,000,000 shares; 80,486,449 shares issued and 80,453,116 shares outstanding as of December 31, 2025; 78,047,798 shares issued and 78,014,465 shares outstanding as of December 31, 2024; | 80,487 | 78,048 |
| Additional paid in capital | 137,418,974 | 134,719,274 |
| Accumulated deficit | (133,775,322) | (128,053,106) |
| Treasury stock, at cost, 33,333 shares | (911,516) | (911,516) |
| Total Milestone Scientific, Inc. stockholders’ equity | 2,812,623 | 5,832,700 |
| Total liabilities and stockholders’ equity | $7,806,429 | $9,797,072 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.